Back
Schwab Fundamental U.S. Small CompanyETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
46
FNDA
Schwab Fundamental U.S. Small CompanyETF
Last Price:
58.74
Seasonality Move:
1.01%
Buy
61
RYTM
Rhythm Pharmaceuticals
Last Price:
45.10
Seasonality Move:
4.7%
Sell
46
Schwab Fundamental U.S. Small CompanyETF (FNDA)
is a Sell
Is Schwab Fundamental U.S. Small CompanyETF a Buy, Sell or Hold?
- The current Schwab Fundamental U.S. Small CompanyETF [FNDA] share price is $57.33. The Score for FNDA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- FNDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $44.23. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FNDA Stock Price Chart
What is Schwab Fundamental U.S. Small CompanyETF's stock price today?
-
The Schwab Fundamental U.S. Small CompanyETF share price today is $57.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FNDA is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $44.23
The current trend is moderately bearish and RYTM is experiencing slight selling pressure.
FNDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 52.83 | Buy |
Chaikin Money Flow: | -144918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.67 - 58.95) | Buy |
Bollinger Bands (100): | (54.18 - 57.44) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 43.39 | Sell |
Chaikin Money Flow: | -164438 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.62 - 48.72) | Sell |
Bollinger Bands (100): | (38.37 - 46.51) | Buy |
FNDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.97 | Buy |
20-day SMA: | 56.99 | Buy |
50-day SMA: | 56.38 | Buy |
200-day SMA: | 54.58 | Buy |
8-day EMA: | 57.05 | Buy |
20-day EMA: | 56.89 | Buy |
50-day EMA: | 56.57 | Buy |
200-day EMA: | 54.6 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.88 | Sell |
20-day SMA: | 45.93 | Sell |
50-day SMA: | 45.45 | Sell |
200-day SMA: | 41.82 | Buy |
8-day EMA: | 45.51 | Sell |
20-day EMA: | 45.9 | Sell |
50-day EMA: | 45.1 | Sell |
200-day EMA: | 40.06 | Buy |
Schwab Fundamental U.S. Small CompanyETF Earnings Growth & FNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.
Schwab Fundamental U.S. Small CompanyETF Technical Analysis
Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | Aug 21 | Aug 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |